José Manuel Puerta, new scientific director of the Andalusian public health Biobank

With a recognized research and healthcare career, he is an area specialist and head of section at the Virgen de las Nieves Hematology and Hemotherapy Day Hospital in Granada.

The head of the medical section of the Hematology and Hemotherapy Day Hospital of the Virgen de las Nieves University Hospital, José Manuel Puerta, has just been appointed by the Ministry of Health and Families as scientific director of the Biobank of the Public Health System of Andalusia, replacing the professor of Medicine Antonio Campos, who has been leading the project for several years.

Puerta joins the Biobank with the intention of consolidating it as a reference for the research community in the collection, selection, preservation and donation of samples for health research. The new scientific director also aims to increase knowledge of the Biobank among health professionals with care work, not only among researchers, so that they can contribute to donation, sample taking and direct participation in their own research projects. of the Biobank.

Likewise, another of the purposes of the new scientific director is to promote knowledge of the Andalusian Registry of Sample Donors for Biomedical Research (REDMI) among citizens, in order to encourage them to donate samples that allow them to continue delving into the research of different pathologies.

Thus, in the Andalusian Registry of Sample Donors for Biomedical Research there are more than two thousand registered individuals whose samples have supported 13 research projects. Donations of biological samples, in general, are essential to facilitate the viability of biomedical research projects that help advance scientific knowledge, diagnosis of diseases, therapeutic efficacy and access to drugs, hence the importance of Society in general knows about it and is encouraged to donate samples.

José Manuel Puerta has a degree in Medicine and Surgery and a doctor from the University of Granada. He has postgraduate training in health management and belongs to various scientific societies, having, among his lines of research, the study of chronic myeloproliferative and lymphoproliferative neoplasms, high-grade lymphomas and the quality of life of the hematological patient.